Home » Topics » Drugs » Immuno-oncology

Immuno-oncology
RSS

Adcetris now available in Japan for Hodgkin's lymphoma or anaplastic large cell lymphoma

April 23, 2014

Alethia develops antibody-drug conjugate targeting KAAG1 for cancer

April 23, 2014

Novel cancer vaccine combined with cyclophosphamide shows potential in a phase I trial

April 23, 2014

Safety, immunogenicity and efficacy of DCVAC/PCa vaccine in recurrent prostate cancer

April 23, 2014

FDA approves ofatumumab in untreated chronic lymphocytic leukemia

April 22, 2014

Lilly's VEGF-inhibiting monoclonal antibody approved for gastric cancer

April 22, 2014

Adamed presents a novel bioconjugate for tumor-targeted drug delivery

April 22, 2014

Chugai to launch trastuzumab emtansine in Japan

April 17, 2014

New anti-CD3 antibodies disclosed by Regeneron Pharmaceuticals

April 17, 2014

Molecular Templates presents novel therapeutic candidate for multiple myeloma

April 16, 2014

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 15, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 14, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
LINC01116 has prognostic value in lung cancer, study shows
BioWorld MedTech
Long noncoding RNAs (lncRNAs) have emerged as potential markers of disease, since they associate with proteins that regulate gene expression, translation or...
SERPINB1 as potential biomarker for spinocerebellar ataxia type 2
BioWorld Science
Researchers from Goethe-Universität and collaborators investigated novel molecular biomarker candidates for spinocerebellar ataxia type 2, a progressive...